Merck Sharpe and Dohme Company Profile

21:58 EST 10th December 2018 | BioPortfolio

News Articles [967 Associated News Articles listed on BioPortfolio]

Merck & Co signs biosimilars deal for US veterans

Merck & Co has signed a deal with the US Department of Veterans Affairs (VA) for its inflammatory diseases biosimilar, Renflexis, so that veterans’ care can be improved. Merck, which is known a...

Merck shelves insulin but wins on Renflexis

Merck Sharp & Dohme has decided that it will not commercialise its tentatively-approved follow-on version of Sanofi’s Lantus (insulin glargine) in the...  

4D Pharma to trial biotherapeutic candidate in combination with Merck's 'KEYTRUDA'

Clinical stage biopharmaceutical company 4D Pharma announced an agreement with a subsidiary of Merck Sharp & Dohme (MSD) on Thursday, to conduct a clinical trial evaluating the combination of 'KEYT...

Dutch court rejects Merck’s SPC on Inegy

A Dutch supplementary protection certificate (SPC) protecting Merck Sharp & Dohme (MSD’s) Inegy (ezetimibe/simvastatin) cholesterol-lowering combination until April next year is invalid... ...

Lung cancer drug Keytruda to become routinely available on NHS

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England. Merck, Sharp, and Dohme (MSD)’s Keytruda (pembrolizumab) will be avai...

Pharma depriving developing countries of taxes - report

A damning report by Oxfam claims that pharma giants are ‘depriving’ developing countries of millions of dollars' worth of tax money annually. Oxfam’s report, Prescription for Poverty, slammed J...

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Merck Co., Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Merck Co., Inc. Strategy, SWOT and Corporate Finance ReportSummaryMerck Co., Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report...

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Aminohippurate sodium [Merck Sharp & Dohme Corp.]


Januvia [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) TabletsInitial U.S. Approval: 20...

Fosamax plus d [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use FOSAMAX PLUS D safely and effectively. See full prescribing information for FOSAMAX PLUS D. FOSAMAX PLUS D(alendronate sodium/cholecal...

A and d original [MSD Consumer Care, Inc.]

A+D Prevent Original Ointment

Primaxin [Merck Sharp & Dohme Corp.]


PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330.

Lithium, which is still the gold standard in the treatment of bipolar disorder, has been proposed to inhibit inositol monophosphatase (IMPase) and is hypothesized to exert its therapeutic effects by a...

Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth.

Background Postpartum hemorrhage is the most common cause of maternal death. Oxytocin is the standard therapy for the prevention of postpartum hemorrhage, but it requires cold storage, which is not av...

Merck vaccine heads Ebola countermeasures.

First person: Arlene Sharpe, MD, PhD: Scientist's work on PD-1 pathway paves the road to key cancer immunotherapies.

Tildrakizumab: First Global Approval.

Merck & Company Inc. have developed tildrakizumab (tildrakizumab-asmn; Ilumya™), a high-affinity, humanised IgG1 κ monoclonal antibody that specifically targets interleukin-23 p19, as a treatment f...

Clinical Trials [89 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

To demonstrate bioequivalence of single dose test formulation of Losartan potassium tablets (containing Losartan potassium 100 mg) of Pharmtechnology LLC, Republic of Belarus with referenc...

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets

To demonstrate the relative bioavailability of Cyclobenzaprine HCl tablets.

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

The objective of this study is to compare the rate and extent of absorption of alendronate sodium 70 mg tablets (test) versus Fosamax® 70 mg tablets (reference) administered as a single d...

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Companies [137 Associated Companies listed on BioPortfolio]

Merck Sharpe and Dohme

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and...

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

More Information about "Merck Sharpe and Dohme" on BioPortfolio

We have published hundreds of Merck Sharpe and Dohme news stories on BioPortfolio along with dozens of Merck Sharpe and Dohme Clinical Trials and PubMed Articles about Merck Sharpe and Dohme for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck Sharpe and Dohme Companies in our database. You can also find out about relevant Merck Sharpe and Dohme Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record